| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Csto | Chief Technical Officer
1 company
Flanagan W. Michael is a Chief Scientific Officer at Avidity Biosciences, Inc.. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $1.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 7, 2026 | RNA Avidity Biosciences, Inc. | Chief Scientific Officer | Sell | 2,373 | $72.23 | $171,401.79 | -2.5% | |
| Sep 11, 2025 | RNA Avidity Biosciences, Inc. | Chief Scientific Officer | Sale+OE | 20,000 | $38.94 | $778,702.00 | -20.0% | |
| Jun 11, 2025 | RNA Avidity Biosciences, Inc. | Chief Scientific Officer | Sale+OE | 20,000 | $32.88 | $657,694.00 | -20.0% | |
| Mar 20, 2025 | RNA Avidity Biosciences, Inc. | Chief Scientific Officer | Sell | 11,780 | $31.06 | $365,867.95 | -12.8% | |
| Mar 11, 2025 | RNA Avidity Biosciences, Inc. | Chief Scientific Officer | Sale+OE | 20,000 | $30.13 | $602,614.00 | -17.9% | |
| Jan 21, 2025 | RNA Avidity Biosciences, Inc. | Chief Scientific Officer | Sell | 5,672 | $28.60 | $162,191.97 | -3.0% | |
| Dec 18, 2024 | RNA Avidity Biosciences, Inc. | Csto | Sell | 12,742 | $32.66 | $416,153.72 | -14.9% | |
| Dec 11, 2024 | RNA Avidity Biosciences, Inc. | Csto | Sale+OE | 24,000 | $35.77 | $858,400.80 | -21.9% | |
| Oct 1, 2024 | RNA Avidity Biosciences, Inc. | Csto | Sale+OE | 62,500 | $47.62 | $2,976,112.50 | -42.3% | |
| Sep 23, 2024 | RNA Avidity Biosciences, Inc. | Csto | Sell | 25,000 | $43.95 | $1,098,732.89 | -13.7% |